Daniel I. Sessler, MD
San Diego—Patients undergoing major upper abdominal or noncardiac thoracic surgery who are at high risk for pulmonary complications may benefit from prophylactic treatment with penehyclidine, according to a randomized trial.
“Pulmonary complications are common after surgery and they’re potentially serious,” said Daniel I. Sessler, MD, the Michael Cudahy Professor and chair of the Department of Outcomes Research at Cleveland Clinic. “Inhalation